Stock Entry Point Article​

Baxter International Inc – Buy Medical Stock

Baxter International Inc – Buy Medical Stock

Baxter International is an American healthcare company that specializes in dialysis therapies, generic injectable pharmaceuticals, sealant products, and surgical hemostat products. Baxter’s products are used by hospitals, nursing homes, kidney dialysis centers, doctor offices, and rehabilitation homes. Baxter International has a manufacturing footprint in more than 20 countries, and it markets its products in over 100 countries. Baxter was affected to a certain extent by the pandemic due to lockdowns and supply chain disruptions. However, with the pandemic subsiding in the US and other select regions of the world, it may be a good time to look at companies that can bounce back. If you are an investor looking for the best medical stocks 2021, then Baxter International could be one name to consider.

More About Baxter International

Baxter International’s stock has decent coverage with a rather positive outlook. There are 14 analysts covering the company who has given the stock a Buy rating. The target prices range from $85 to $99. Prices have been in a downtrend since April 2021, with lower highs and lower lows. The longer-term trend has been sideways movements for the past 6-odd months. However, the monthly chart suggests that the price is taking a breather after having advanced for more than four years. Prices have more than doubled during that time and maybe consolidating before a possible resumption of the uptrend. Baxter International was founded in the year 1931 in Deerfield, Illinois. The company has been around for many decades and is among the leaders in intravenous fluids and dialysis therapies. If you are looking to buy medical stock, then Baxter International may be worth analyzing further.

Best Medical Stocks 2021

Baxter International trades on the New York stock exchange under the ticker symbol BAX. The stock last closed at $81.07 on 6th July 2021. Its 52-week high was $91.45, while the 52-week low was $74.79. The stock price was flat on a 1-month basis, down 0.23%.


Share on facebook
Share on twitter
Share on linkedin

More Posts

Send Us A Message